Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version
dc.date.accessioned | 2022-05-26T13:26:31Z | |
dc.date.available | 2022-05-26T13:26:31Z | |
dc.date.issued | 2021-12-03 | |
dc.identifier.citation | PDQ® Adult Treatment Editorial Board. PDQ Gestational Trophoblastic Disease Treatment. Bethesda, MD: National Cancer Institute. Updated <MM/DD/YYYY>. Available at: https://www.cancer.gov/types/gestational-trophoblastic/patient/gtd-treatment-pdq. Accessed <MM/DD/YYYY>. [PMID: 26389509] | en_US |
dc.identifier.uri | http://hdl.handle.net/123456789/1458 | |
dc.language.iso | en_US | en_US |
dc.publisher | National cancer Institute | en_US |
dc.subject | Gestational trophoblastic disease (GTD) | en_US |
dc.subject | Hydatidiform mole (HM) | en_US |
dc.subject | Gestational trophoblastic neoplasia (GTN) | en_US |
dc.title | Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version - National Cancer Institute.html
- Size:
- 232.61 KB
- Format:
- Hypertext Markup Language
- Description:
- Main article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: